TH1834 is a selective small-molecule inhibitor of the Tip60/KAT5 histone acetyltransferase. It triggers DNA damage and apoptosis in breast cancer cells like MCF-7, while sparing the related MOF acetyltransferase, making it a useful research tool for studying chromatin biology and cancer mechanisms in vitro.